Offer : pcd pharma franchise , third party manufacturing
MONTOLIFE-FX TABLETS
Fexofenadine 120mg + Montelukast 10 mg Tablets
Indications :
ALLERGIC RHINITIS
ASTHMA
Montelukast
Active , Highly Selective Cysteinyl Leukotriene Type -1 Receptor Antagonist Of Leukotrine D4, With Affinities Approximately Two – Fold Greater Than The Natural Ligand.
Effective Therapy For Asthma In Children Aged 2 To 5 Years And Is Well Tolerated Without Adverse Effects.
Leukotriene Receptor Antagonist, Significantly Improves Daytime & Nighttime Symptoms In Patients With AR3 .
Produces Significant Relif Of Airway Obstruction Throught The 2 Hours After Administration , With An Onset Of Action As Early As 10 Minutes.
Significantly Reduces The Number Of Peripheral Blood Eosinophils , Thereby Reducing Allergic Inflammation In Patients With AR5
Immproves Symptoms Of Seasonal AR Including Nasal Congestion , Sneezing & Nasal Discharge.
Fexofenadine :
Significantly More Effective Than Loratagine In Relieving Eye Symptoms And Nasal Congestion .
Effective In Relieving The Symptoms Of Sneezing , Rhinorrhoea , Itchy Nose Palate Or Throat, And Itchy , Watery ,Red Eyes In Patients With Seasonal Allergic Rhinitis.
A Selective Histamine H1 Receptor Antagonist That Does Not Cross The Blood Brain Barrier & Shows Some Anti – Inflammatory Properties &Rapid Absorption
With Long Duration Of Action.
